Operating Lease, Right-of-Use Asset in USD of Adicet Bio, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Adicet Bio, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2019 to Q3 2025.
  • Adicet Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $11.9M, a 20.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Adicet Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $11.9M -$3.15M -20.9% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $12.6M -$3.3M -20.8% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $13.4M -$3.26M -19.6% 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $14.2M -$3.2M -18.3% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $15.1M -$3.14M -17.2% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $15.9M -$3.08M -16.3% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $16.6M -$3.06M -15.5% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $17.4M -$2.85M -14% 31 Dec 2023 10-K 06 Mar 2025
Q3 2023 $18.2M -$2.81M -13.4% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $18.9M -$2.47M -11.5% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $19.7M -$5K -0.03% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $20.3M -$89K -0.44% 31 Dec 2022 10-K 19 Mar 2024
Q3 2022 $21M +$126K +0.6% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $21.4M -$291K -1.34% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $19.7M -$2.67M -11.9% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $20.4M -$2.71M -11.7% 31 Dec 2021 10-K 15 Mar 2023
Q3 2021 $20.9M 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $21.7M 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $22.4M 31 Mar 2021 10-Q 17 May 2021
Q4 2020 $23.1M +$21.7M +1548% 31 Dec 2020 10-K 15 Mar 2022
Q4 2019 $1.4M 01 Jan 2020 10-K 12 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.